The Role of Natural Killer Cells in Alzheimer's Disease

Scandinavian Journal of Immunology

Volumn 76, Issue 5, 2012, Pages 451-456

  Jadidi Niaragh, F ^a   Shegarfi, H ^b   Naddafi, F ^c   Mirshafiey, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR;

ALZHEIMER DISEASE; CELL FUNCTION; CYTOPATHOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; NATURAL KILLER CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, NATURAL KILLER CELL;

EID: 84867425831     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02769.x     Document Type: Review

References (64)

1. Galimberti D, Scarpini E. Progress in Alzheimer's disease. J Neurol 2012;259:201-11.
2. Carrillo MC, Blackwell A, Hampel H et al. Early risk assesssment for Alzheimer's disease. Alzheimers & Dementia 2009;5:182-96.
3. Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LFCerebrospinal fluid tau, A beta(1-42) and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci Lett 2005;383:12-6.
4. Carson MJ, Sutcliffe JG. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 1999;55:1-8.
5. Mulder SD, Veerhuis R, Blankenstein MA, Nielsen HMThe role of amyloid associated proteins in amyloid-beta clearance by primary adult human microglia and astrocytes. Glia 2011;59:S145-S145.
6. Breitner JC, Murphy EA, Folstein MF, Magruder-Habib K. Twin studies of Alzheimer's disease: an approach to etiology and prevention. Neurobiol Aging 1990;11:641-8.
7. Masera RG, Prolo P, Sartori ML et al. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease. Psychoneuroendocrinology 2002;27:447-61.
8. Trachtenberg EA. Understanding the role of natural killer cell receptors and their human leukocyte antigen ligands in multiple sclerosis. Ann Neurol 2009;65:626-8.
9. Richartz-Salzburger E, Batra A, Stransky E. Altered lymphocyte distribution in Alzheimer's disease. J Psychiatr Res 2007;41:174-8.
10. Kiessling R, Klein E, Pross H, Wigzell H. "Natural"-killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975;5:117-21.
11. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975;16:230-9.
12. Di Santo JP, Vosshenrich CAJ. Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev 2006;214:35-46.
13. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004;22:405-29.
14. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 2009;9:568-80.
15. Lanier LL. Nk cell recognition. Annu Rev Immunol 2005;23:225-74.
16. Di Santo JP. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006;24:257-86.
17. Wu J, Lanier LL. Natural Killer Cells and Cancer. Adv Cancer Res 2003;90:127-56.
18. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009;457:557-61.
19. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006;7:507-16.
20. Grégoire C, Chasson L, Luci C et al. The trafficking of natural killer cells. Immunol Rev 2007;220:169-82.
21. Huang D, Shi FD, Jung S et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 2006;20:896-905.
22. Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675-8.
23. Orr MT, Lanier LL. Natural killer cell education and tolerance. Cell 2010;142:847-56.
24. Kumar V, McNerney ME. A new self: MHC-class-I-independent Natural-killer-cell self-tolerance. Nat Rev Immunol 2005;5:363-74.
25. Pellicanò M, Larbi A, Goldeck D. et al. Immune profiling of Alzheimer patients. J Neuroimmunol 2012;242:52-9.
26. Speciale L, Calabrese E, Saresella M et al. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol Aging 2007;28:1163-9.
27. Solerte SB, Fioravanti M, Pascale A, Ferrari E, Govoni S, Battaini F. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol Aging 1998;19:191-9.
28. Morandi B, Bramanti P, Bonaccorsi I et al. Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol Res 2008;57:1-5.
29. Krishnaraj R. Immunomodulation by 9-amino-1, 2, 3, 4-tetrahydroacridine (THA): 1. Down-regulation of natural cell-mediated cytotoxicity in vitro. Immunopharmacology 1991;22:69-76.
30. Araga S, Kagimoto H, Funamoto K, Takahashi K. Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta Neurol Scand 1991;84:259-63.
31. Irwin M, Brown M, Patterson T, Hauger R, Mascovich A, Grant I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J 1991;5:3100-7.
32. Solerte SB, Fioravanti M, Severgnini S et al. Enhanced cytotoxic response of natural killer cells to interleukin-2 in Alzheimer's disease. Dementia 1996;7:343-8.
33. Solerte SB, Cerutti N, Severgnini S, Rondanelli M, Ferrari E, Fioravanti M. Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1998;9:149-56.
34. Solerte SB, Ceresini G, Ferrari E, Fioravanti M. Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system. Neurobiol Aging 2000;21:271-81.
35. Solerte SB, Cravello L, Ferrari E, Fioravanti M. Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Ann N Y Acad Sci 2000;917:331-40.
36. Ferrari E, Fioravanti M, Magri F, Solerte SB. Variability of interactions between neuroendocrine and immunological functions in physiological aging and dementia of the Alzheimer's type. Ann N Y Acad Sci 2000;917:582-96.
37. Solerte SB, Ferrari E, Cuzzoni G et al. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate. Dement Geriatr Cogn Disord 2005;19:1-10.
38. Schindowski K, Peters J, Gorriz C et al. Apoptosis of CD4(+) T and natural killer cells in Alzheimer's disease. Pharmacopsychiatry 2006;39:220-8.
39. Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: the challenge of the second century. Sci Transl Med 2011;3:77sr1.
40. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011;377:1019-31.
41. Galimberti D, Scarpini E. Alzheimer's disease: from pathogenesis to disease-modifying approaches. CNS Neurol Disord Drug Targets 2011;10:163-74.
42. Zimmer J, Bausinger H, de la Salle H. Autoimmunity mediated by innate immune effector cells. Trends Immunol 2001;22:300-1.
43. Hammarberg H, Lidman O, Lundberg C et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 2000;20:5283-91.
44. Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T. The regulatory role of natural killer cells in multiple sclerosis. Brain 2004;127:1917-27.
45. Backström E, Chambers BJ, Ho EL et al. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol 2003;33:92-100.
46. Matsumoto Y, Kohyama K, Aikawa Y et al. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur J Immunol 1998;28:1681-8.
47. Smeltz RB, Wolf NA, Swanborg RH. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J Immunol 1999;163:1390-7.
48. Shi FD, Takeda K, Akira S, Sarvetnick N, Ljunggren HG. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J Immunol 2000;165:3099-104.
49. Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, Shi FD. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 2005;174:2696-701.
50. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997;186:1677-87.
51. Segal BM. The role of natural killer cells in curbing neuroinflammation. J Neuroimmunol 2007;191:2-7.
52. Bielekova B, Catalfamo M, Reichert-Scrivner S et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2R alpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Nat Acad Sci USA 2006;103:5941-6.
53. Saraste M, Irjala H, Airas L. Expansion of CD56(Bright) natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol Sci 2007;28:121-6.
54. Infante-Duarte C, Weber A, Krätzschmar J et al. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J 2005;19:1902-4.
55. Morandi B, Bougras G, Muller WA, Ferlazzo G, Münz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol 2006;36:2394-400.
56. MartÍn-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004;5:1260-5.
57. Horwitz DA, Gray JD, Ohtsuka K. Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect 1999;1:1305-11.
58. Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009;21:634-40.
59. Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett 2007;114:46-51.
60. Bernstein HB, Plasterer MC, Schiff SE, Kitchen CM, Kitchen S, Zack JA. CD4 expression on activated NK cells: Ligation of CD4 induces cytokine expression and cell migration. J Immunol 2006;177:3669-76.
61. Abraha AB, Rana K, Whalen MM. Role of protein kinase C in TBT-induced inhibition of lytic function and MAPK activation in human natural killer cells. Arch Environ Contam Toxicol 2010;59:661-9.
62. Itzhaki RF, Wozniak MA. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?Alzheimers Demen 2010;6:83-4.
63. Holmes C, Cotterell D. Role of infection in the pathogenesis of Alzheimer's disease implications for treatment. CNS Drugs 2009;23:993-1002.
64. Alloul K, Sauriol L, Kennedy W et al. Alzheimer's disease: a review of the disease, its epidemiology and economic impact. Arch Gerontol Geriatr 1998;27:189-221.